WallStreetZenWallStreetZen

NASDAQ: MRKR
Marker Therapeutics Inc Earnings & Revenue

MRKR past revenue growth

How has MRKR's revenue growth performed historically?
Company
-5.76%
Industry
165.61%
Market
17.84%
MRKR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MRKR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MRKR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MRKR earnings and revenue history

Current Revenue
$3.3M
Current Earnings
-$8.2M
Current Profit Margin
-248.8%

MRKR Return on Equity

Current Company
-50.1%
Current Industry
-63.6%
Current Market
188%
MRKR's Return on Equity (-50.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MRKR announces earnings.

MRKR Return on Assets

Current Company
-38.1%
Current Industry
3%
MRKR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MRKR Return on Capital Employed

Current Company
-58.59%
Current Industry
19.6%
MRKR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MRKR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MRKR$3.31M-$8.23M-$8.24M+74.27%N/A
FBIO$84.51M-$36.73M-$68.67M+25.75%N/A
OKYO$0.00-$13.18M-$13.27MN/AN/A
ACXP$0.00-$14.58M-$14.58MN/AN/A
EVGN$5.64M-$20.34M-$23.88M+26.41%N/A

MRKR earnings dates

Next earnings date
May 13, 2024

Marker Therapeutics Earnings & Revenue FAQ

What were MRKR's earnings last quarter?

On Invalid Date, Marker Therapeutics (NASDAQ: MRKR) reported Q4 2023 earnings per share (EPS) of -$0.32, up 28.89% year over year. Total Marker Therapeutics earnings for the quarter were -$2.80 million. In the same quarter last year, Marker Therapeutics's earnings per share (EPS) was -$0.45.

If you're new to stock investing, here's how to buy Marker Therapeutics stock.

What was MRKR's earnings growth in the past year?

As of Q1 2024, Marker Therapeutics's earnings has grown year over year. Marker Therapeutics's earnings in the past year totalled -$8.24 million.

What is MRKR's earnings date?

Marker Therapeutics's earnings date is Invalid Date. Add MRKR to your watchlist to be reminded of MRKR's next earnings announcement.

What was MRKR's revenue last quarter?

On Invalid Date, Marker Therapeutics (NASDAQ: MRKR) reported Q4 2023 revenue of $1.06 million up 39.17% year over year. In the same quarter last year, Marker Therapeutics's revenue was $759.14 thousand.

What was MRKR's revenue growth in the past year?

As of Q1 2024, Marker Therapeutics's revenue has grown -5.76% year over year. This is 171.37 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Marker Therapeutics's revenue in the past year totalled $3.31 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.